Dendrimer-conjugated isotretinoin for controlled transdermal drug delivery

BACKGROUND: In the present study, we aimed to develop a novel isotretinoin delivery model for treating skin diseases, revealing its potential advantages in drug delivery and targeted therapy. Using a self-assembly strategy, we grafted a dendrimer, based on a well-defined branched structure for nanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianqi, Zhou, Mingwei, Wu, Ronghui, Wang, Huaxin, Zouboulis, Christos C., Zhu, Mingji, Lee, Myongsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464058/
https://www.ncbi.nlm.nih.gov/pubmed/37605256
http://dx.doi.org/10.1186/s12951-023-02052-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464058/
https://www.ncbi.nlm.nih.gov/pubmed/37605256
http://dx.doi.org/10.1186/s12951-023-02052-5

Ejemplares similares